LIVE MARKET TRACKER :   BSE SENSEX   33053.04      |    NSE NIFTY 10192.95    
GLOBAL MARKETS :  NASDAQ      |    FSI London      |    NIKKEI Japan  
  USD GBP EUR CAD AUD INR
USD -
GBP -
EUR -
CAD -
AUD -
INR -
Indian-Commodity  :  Equity & Shares  :  Pfizer declines on reporting 29% fall in Q1 net profit

Pfizer declines on reporting 29% fall in Q1 net profit (31-Jul-2017)

Pfizer is currently trading at Rs. 1752.50, down by -34.95 points or 1.96% from its previous closing of Rs. 1787.45 on the BSE.

The scrip opened at Rs. 1780.00 and has touched a high and low of Rs. 1780.00 and Rs. 1736.05 respectively. So far 859 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 2055.00 on 09-Sep-2016 and a 52 week low of Rs. 1625.00 on 08-Jun-2017.

Last one week high and low of the scrip stood at Rs. 1823.05 and Rs. 1736.05 respectively. The current market cap of the company is Rs. 8060.75 crore.

The promoters holding in the company stood at 63.92%, while Institutions and Non-Institutions held 13.98% and 22.09% respectively.

Pfizer has reported 28.57% fall in its net profit at Rs 57.17 crore for first quarter ended June 30, 2017, as compared to Rs 80.04 crore for the same quarter in the previous year. Total income of the company decreased by 15.22% at Rs 459.86 crore for Q1FY18 as compared Rs 542.41 crore for the corresponding quarter previous year.

Pfizer has produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.


Top News Today
Talwalkars commences construction of first leisure club in Pune
(13-Dec-2017)

Talwalkars commences construction of first leisure club in PuneTalwalkars Better Value Fitness has commenced the construction of its first leisure club in Wakad, Pune. Post the compliance of various statutory procedures, the club project has received necessary sanctions......click on news to read complete article.

NIIT features in '2017 Top 20 IT Training Company' list
(13-Dec-2017)

NIIT features in NIIT has been featured by Training Industry among 2017 Top 20 IT Training Company for the eighth consecutive year. Training Industry is one of the most trusted sources of information on the business of......click on news to read complete article.

Orchid Pharma receives ANDA approval for Aripiprazole Orally-Disintegrating Tablets
(13-Dec-2017)

Orchid Pharma receives ANDA approval for Aripiprazole Orally-Disintegrating TabletsOrchid Pharma has received ANDA approval from USFDA for Aripiprazole Orally-Disintegrating Tablets USP, 10 mg and 15 mg. Aripiprazole Orally-Disintegrating Tablets are atypical antipsychotic, indicated......click on news to read complete article.

International Stock News
US markets closed higher on Monday
(12-Dec-2017)

US markets closed higher on MondayThe US markets closed higher on Monday, with the S&P 500 index and Dow industrials closing at records on the back of a rally in telecommunications and technology shares. Wall Street shrugged off......click on news to read complete article.

Asian markets trade higher in early deals on Monday
(11-Dec-2017)

Asian markets trade higher in early deals on MondayAsian equity benchmark indices are trading higher in the early deals on Monday, lifted by encouraging employment data from the US that took the Standard & Poor's 500 Index to its third straight......click on news to read complete article.

US markets end at record highs on upbeat jobs data
(09-Dec-2017)

US markets end at record highs on upbeat jobs dataThe US markets traded with traction and ended near record high levels on Friday, as traders reacted positively to the closely watched monthly jobs report. The continued advance by stocks came following......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.